speb/financial-data huggingface dataset:
GLAND.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -628240000.00
GLAND.NS income_statement (annual, 2025-03-31) — Research And Development: 332840000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 150000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 150000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 71568710000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 71568710000.00
GLAND.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 24400460000.00
GLAND.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 3380000.00
GLAND.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 274820000.00
GLAND.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1411210000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Share Issued: 164756423.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 164756423.00
GLAND.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
GLAND.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
GLAND.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 0.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 91507410000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 91507410000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 87968390000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 87968390000.00
GLAND.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GLAND.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GLAND.NS income_statement (annual, 2025-03-31) — Tax Provision: 3641320000.00
GLAND.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 1017920000.00
GLAND.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.34
GLAND.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.35
GLAND.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -3538030000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Total Assets: 112249200000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 112249200000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 92284050000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 92284050000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Total Debt: 3137330000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 3137330000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 91507410000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 91507410000.00
GLAND.NS income_statement (annual, 2025-03-31) — Total Expenses: 47254540000.00
GLAND.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 11731550000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 20741790000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 20741790000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 44419820000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 44419820000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 5093340000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 5093340000.00
GLAND.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 46010000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 736880000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 736880000.00
GLAND.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
GLAND.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
GLAND.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GLAND.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Work In Process: 4366170000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 4366170000.00
GLAND.NS balance_sheet (annual, 2025-03-31) — Working Capital: 52180930000.00
GLAND.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 52180930000.00
GLAND.NS income_statement (annual, 2025-03-31) — Write Off: 56760000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 7177770000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 15056220000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 164741590.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 13.08
GLAND.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 5211350000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1010520000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 1010520000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 164741590.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 13.08
GLAND.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2154820000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — EBIT: 3242370000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — EBITDA: 4252890000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 9844870000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 114960000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 114960000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Net Income: 2154820000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2154820000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2154820000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2154820000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2154820000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2154820000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -114960000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -114960000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 4252890000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 2154820000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Operating Income: 2667100000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 15056220000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 575270000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 2086870000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 3127410000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 5211350000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1010520000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 972590000.00
GLAND.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.31
GLAND.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 12389120000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 7914810000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 16953630000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 164760555.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 15.87
GLAND.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 5766510000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1076450000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1076450000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 164760555.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 15.87
GLAND.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2614750000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — EBIT: 3660580000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — EBITDA: 4737030000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 11187120000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 39300000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 39300000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Net Income: 2614750000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2614750000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2614750000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2614750000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2614750000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2614750000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -39300000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -39300000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 4980490000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 2790540614.09
GLAND.NS income_statement (quarterly, 2025-12-31) — Operating Income: 3272310000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 16953630000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 631730000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 2596390000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 3621280000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 5766510000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1076450000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -243460000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -67669385.91
GLAND.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 1006530000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.28
GLAND.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 13681320000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -243460000.00
GLAND.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -243460000.00
GLAND.NS income_statement (annual, 2026-03-31) — +Operating Expense: 29818430000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 7470990000.00
GLAND.NS income_statement (annual, 2026-03-31) — +Total Revenue: 64306500000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 17427900000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 8338740000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8338740000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 18913820000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 18913820000.00
GLAND.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 164765998.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 164723720.00
GLAND.NS income_statement (annual, 2026-03-31) — Basic EPS: 62.35
GLAND.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 22.26
GLAND.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 25562090000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -4944290000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 402300000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 402300000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 164760000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 164760000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 33591060000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 33591060000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 34328470000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 34328470000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -2965510000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 187230000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 836310000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Change In Payable: -548830000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -2786180000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -2544950000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 7521440000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Common Stock: 164760000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 164760000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 103579500000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 103579500000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 0.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 3421790000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 3421790000.00
GLAND.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 22429300000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 5913310000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Current Assets: 75267850000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 75267850000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 169280000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 169280000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1734350000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1734350000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1903630000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1903630000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 16084030000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 16084030000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 541350000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 541350000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Depreciation: 4236670000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 4236670000.00
GLAND.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 4236670000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1086600000.00
GLAND.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 4236670000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1086600000.00
GLAND.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 164951188.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 164946019.00
GLAND.NS income_statement (annual, 2026-03-31) — Diluted EPS: 62.28
GLAND.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 22.23
GLAND.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 10273160000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 3666750000.00
GLAND.NS income_statement (annual, 2026-03-31) — EBIT: 14978590000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — EBIT: 5158260000.00
GLAND.NS income_statement (annual, 2026-03-31) — EBITDA: 19215260000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — EBITDA: 6244860000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 507530000.00
GLAND.NS cash_flow (annual, 2026-03-31) — End Cash Position: 33591060000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -4169710000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 5369580000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -33060000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 3840000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Goodwill: 2938700000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 2938700000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 4024860000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 4024860000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 44320210000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 44320210000.00
GLAND.NS income_statement (annual, 2026-03-31) — Gross Profit: 41877200000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 11514590000.00
GLAND.NS income_statement (annual, 2026-03-31) — Interest Expense: 332790000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 100300000.00
GLAND.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 332790000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 100300000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -323580000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 2322620000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Inventory: 17438890000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 17438890000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 106013100000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 106013100000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 1377280000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 0.00
GLAND.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 225230000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 233020000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 233020000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 699250000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 699250000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 932270000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 932270000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 225230000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -937570000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 1956400000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 1956400000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 0.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 0.00
GLAND.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
GLAND.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
GLAND.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -418420000.00
GLAND.NS income_statement (annual, 2026-03-31) — Net Income: 10273160000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Net Income: 3666750000.00
GLAND.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 10273160000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 3666750000.00
GLAND.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 10273160000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3666750000.00
GLAND.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 10273160000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3666750000.00
GLAND.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 10273160000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3666750000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 14645800000.00
GLAND.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 10273160000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3666750000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -36660000.00
GLAND.NS income_statement (annual, 2026-03-31) — Net Interest Income: -332790000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -100300000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 3993060000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -712340000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -712340000.00
GLAND.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -332790000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -100300000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Net PPE: 44320210000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 44320210000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -4901740000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 99554640000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 99554640000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 623250000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 623250000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2143820000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2143820000.00
GLAND.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 19458720000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 6244860000.00
GLAND.NS income_statement (annual, 2026-03-31) — Normalized Income: 10443932749.43
GLAND.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 3666750000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 10313870000.00
GLAND.NS income_statement (annual, 2026-03-31) — Operating Income: 12058770000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Operating Income: 4043600000.00
GLAND.NS income_statement (annual, 2026-03-31) — Operating Revenue: 64306500000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 17427900000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 164756423.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 164756423.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 4586670000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4586670000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 3184810000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 3184810000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 103414740000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 103414740000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1086160000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1086160000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -1479210000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 775390000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 775390000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 412460000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 412460000.00
GLAND.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 3163280000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1114660000.00
GLAND.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 9293370000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 2268650000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Other Properties: 40898420000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 40898420000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 737410000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 737410000.00
GLAND.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Payables: 8967340000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Payables: 8967340000.00
GLAND.NS income_statement (annual, 2026-03-31) — Pretax Income: 14645800000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 5057960000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 1820000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -36660000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -7439630000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -4907630000.00
GLAND.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 22429300000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 5913310000.00
GLAND.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 4236670000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1086600000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -937570000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 11432690000.00
GLAND.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 5890000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Share Issued: 164756423.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 164756423.00
GLAND.NS income_statement (annual, 2026-03-31) — Special Income Charges: -243460000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
GLAND.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 454680000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 103579500000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 103579500000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 99554640000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 99554640000.00
GLAND.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -72687250.57
GLAND.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
GLAND.NS income_statement (annual, 2026-03-31) — Tax Provision: 4372640000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 1391210000.00
GLAND.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.30
GLAND.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.28
GLAND.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -4554530000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Total Assets: 125108480000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 125108480000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 104278750000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 104278750000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Total Debt: 2835900000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2835900000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 103579500000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 103579500000.00
GLAND.NS income_statement (annual, 2026-03-31) — Total Expenses: 52247730000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 13384300000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 21528980000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 21528980000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 49840630000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 49840630000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5444950000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5444950000.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 628600000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 628600000.00
GLAND.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -243460000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
GLAND.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -243460000.00
GLAND.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GLAND.NS balance_sheet (annual, 2026-03-31) — Working Capital: 59183820000.00
GLAND.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 59183820000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -2226550000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 26200000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -202324000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Amortization: 94696000.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 94696000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 1123000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 169406034.00
GLAXO.NS income_statement (annual, 2022-03-31) — Basic EPS: 100.04
GLAXO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1040809000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 2300600000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 561271000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Current Debt: 0.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Deferred Tax: 82826000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 169406034.00
GLAXO.NS income_statement (annual, 2022-03-31) — Diluted EPS: 100.04
GLAXO.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 182805000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 4228290000.00
GLAXO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 541199000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 2254713000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: -17010000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Interest Income: 711528000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 711528000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 22488000.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -240000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 3936956000.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
GLAXO.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 13139504000.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Net Investment Properties Purchase And Sale: 323424000.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -240000.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -240000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 578890000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 344974000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 4671849000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 420048000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 1109902000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 18129000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 18129000.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -240000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 192207000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 200843000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 17314970000.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
GLAXO.NS cash_flow (annual, 2022-03-31) — Sale Of Investment Properties: 323424000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1831034000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 2372233000.00
GLAXO.NS balance_sheet (annual, 2022-03-31) — Work In Process: 8762000.00
GLAXO.NS income_statement (annual, 2022-03-31) — Write Off: 14402000.00
GLAXO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 11192293000.00
GLAXO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 32263787000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 4277887000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1923750000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -2555443000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 26200000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -128680000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Amortization: 96942000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 96942000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 265000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 169406034.00
GLAXO.NS income_statement (annual, 2023-03-31) — Basic EPS: 36.05
GLAXO.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 2861871000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1084136000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -440391000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 155392000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 1694060000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 349409000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 16541197000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -15254999000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 400000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 349009000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 747250000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -438119000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -252840000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Change In Payable: -1532150000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 202283000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -457456000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -2512462000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Common Stock: 1694060000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -15254999000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 17412730000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 203118000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 13587230000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Current Assets: 24942645000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 120838000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 120838000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 13263701000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 4177910000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Defined Pension Benefit: 0.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Depreciation: 657672000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 657672000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 657672000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 560730000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 169406034.00
GLAXO.NS income_statement (annual, 2023-03-31) — Diluted EPS: 36.05
GLAXO.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 6106868000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 191246000.00
GLAXO.NS income_statement (annual, 2023-03-31) — EBIT: 8382122000.00
GLAXO.NS income_statement (annual, 2023-03-31) — EBITDA: 9039794000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — End Cash Position: 349409000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -15433230000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 3490911000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 4401863000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -307785000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -278000.00
GLAXO.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 408194000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 340908000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 2052430000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 5706630000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Gross Profit: 18676557000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 0.00
GLAXO.NS income_statement (annual, 2023-03-31) — Interest Expense: 18122000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 18122000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Interest Income: 698119000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 698119000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -13978000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 629719000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Inventory: 4599704000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 17412730000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 8078514000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 10619000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 265000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 37003000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 34554000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 34554000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: 0.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 2548032000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 4244379000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Net Income: 6106868000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 6106868000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 6076422000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: 30446000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 6106868000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 6076422000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 8414942000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 6106868000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Net Interest Income: 679997000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Net Investment Properties Purchase And Sale: 97800000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 9562920000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 0.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 0.00
GLAXO.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 679997000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 4424000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -2986099000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Net PPE: 3151187000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -425826000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 17071822000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 1335460000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 586785000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 8741410000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Normalized Income: 5859616185.60
GLAXO.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 4842254000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Operating Income: 7484264000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Operating Revenue: 32263787000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 169406034.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 31880000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 594000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: -16772000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 340908000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -675990000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 10774000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 428000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 2728963000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Other Payable: 1449380000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Other Properties: 137994000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 1376526000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 16191788000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Other Special Charges: -104294000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Payables: 8880548000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 268613000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Pretax Income: 8364000000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -73644000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -52642926000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -440391000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1099274000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 13587230000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 657672000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 20979000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 20979000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 200975000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 113695000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 8114914000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 62205846000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Sale Of Investment Properties: 97800000.00
GLAXO.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 14565000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1662579000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 2070773000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Share Issued: 169406034.00
GLAXO.NS income_statement (annual, 2023-03-31) — Special Income Charges: -9401000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 17412730000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 17071822000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 81578185.60
GLAXO.NS income_statement (annual, 2023-03-31) — Tax Provision: 2287578000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.27
GLAXO.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -2624152000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 33265848000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 17412730000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 155392000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 17412730000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Total Expenses: 24779523000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 15853118000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 8323203000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 2589417000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 2962035000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 298384000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 298384000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Work In Process: 9519000.00
GLAXO.NS balance_sheet (annual, 2023-03-31) — Working Capital: 11678944000.00
GLAXO.NS income_statement (annual, 2023-03-31) — Write Off: 0.00
GLAXO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 11834367000.00
GLAXO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 34417708000.00